Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and

Gabriella Pietra1, Claudia Manzini, Silvia Rivara

  • 1Dipartimento di Medicina Sperimentale and Centro di Eccellenza per la Ricerca Biomedica Università degli Studi di Genova, Genova, Italy.

Cancer Research
|January 20, 2012
PubMed

Insights

Melanoma cells suppress natural killer (NK) cell anti-tumor functions by inhibiting key receptors. Tumor-derived factors like indoleamine 2,3-dioxygenase (IDO) and prostaglandin E2 (PGE2) reduce NK cell effectiveness, hindering cancer immunotherapy.

Area of Science:

  • Immunology
  • Cancer Biology
  • Cellular Immunology

Background:

  • Natural killer (NK) cells are crucial for identifying and eliminating cancerous cells.
  • Adoptive NK cell immunotherapy shows promise but faces challenges due to tumor immune evasion.
  • Understanding tumor-NK cell interactions is vital for improving cancer treatment strategies.

Purpose of the Study:

  • To investigate how melanoma cells affect NK cell phenotype and function.
  • To identify the mechanisms by which tumors inhibit NK cell-mediated anti-tumor activity.
  • To explore potential therapeutic targets for overcoming NK cell suppression in cancer.

Main Methods:

  • Coculturing of human melanoma cell lines and primary NK cells.
  • Flow cytometry analysis of NK cell receptor expression (NKp30, NKp44, NKG2D).
  • Assessment of NK cell-mediated cytolytic activity against melanoma targets.
  • Investigating the role of indoleamine 2,3-dioxygenase (IDO) and prostaglandin E2 (PGE2) in mediating inhibition.

Main Results:

  • Melanoma cells significantly reduced the expression of key NK cell activating receptors (NKp30, NKp44, NKG2D).
  • This downregulation impaired NK cell cytotoxic function against melanoma cell lines.
  • Indoleamine 2,3-dioxygenase (IDO) and prostaglandin E2 (PGE2) were identified as major mediators of this immunosuppressive effect.
  • Tumor-induced suppression of NK cells was observed across various melanoma cell lines.

Conclusions:

  • Tumor cells create an immunosuppressive microenvironment that compromises NK cell anti-tumor activity.
  • IDO and PGE2 are critical factors in melanoma's ability to evade NK cell surveillance.
  • Targeting these immunosuppressive pathways could enhance the efficacy of NK cell-based cancer immunotherapies.

Related Concept Videos

Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...